Metraipolis › archive › dc_e85e4ed79c55

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients — Europe PMC PMID:41936750

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41936750
DOI
10.1016/j.tranon.2026.102756
License (as archived)
solo-consultazione
Archived
2026-11-03T08:55:24.224Z
SHA-256 of the archived text
173c0a2a6c065fc85209047b4af4814e8bddc4aff88fb634b6a7bbaaf0c9896a
Stable URL of this page
https://metraipolis.com/documento/dc_e85e4ed79c55

How to cite

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients — Europe PMC PMID:41936750 — Europe PMC (en), https://europepmc.org/article/MED/41936750 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e85e4ed79c55 (Metraipolis archive dc_e85e4ed79c55, sha256 173c0a2a6c065fc85209047b4af4814e8bddc4aff88fb634b6a7bbaaf0c9896a)
BibTeX
@misc{dce85e4ed79c55,
  title = {Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients — Europe PMC PMID:41936750},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41936750},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e85e4ed79c55; sha256 173c0a2a6c065fc85209047b4af4814e8bddc4aff88fb634b6a7bbaaf0c9896a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41936750. Agents can read the archived copy with the MCP tool read_document.